Haston W - Search Results

1

Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.

Pellas TC, Boyar W, van Oostrum J, Wasvary J, Fryer LR, Pastor G, Sills M, Braunwalder A, Yarwood DR, Kramer R, Kimble E, Hadala J, Haston W, Moreira-Ludewig R, Uziel-Fusi S, Peters P, Bill K, Wennogle LP. Pellas TC, et al. Among authors: haston w. J Immunol. 1998 Jun 1;160(11):5616-21. J Immunol. 1998. PMID: 9605167

2

Characterization of the binding of Bolton-Hunter labeled [125I]C5a to human neutrophil, monocyte and U-937 cell membranes.

Braunwalder AF, Musmanno D, Galakatos N, Garlick RH, Haston WO, Rediske JJ, Wennogle L, Seligmann B, Sills MA. Braunwalder AF, et al. Among authors: haston wo. Mol Immunol. 1992 Nov;29(11):1319-24. doi: 10.1016/0161-5890(92)90168-w. Mol Immunol. 1992. PMID: 1406720

3

The pharmacophore of the human C5a anaphylatoxin.

Toth MJ, Huwyler L, Boyar WC, Braunwalder AF, Yarwood D, Hadala J, Haston WO, Sills MA, Seligmann B, Galakatos N. Toth MJ, et al. Among authors: haston wo. Protein Sci. 1994 Aug;3(8):1159-68. doi: 10.1002/pro.5560030802. Protein Sci. 1994. PMID: 7987211 Free PMC article.

4

LTB4-induced transient neutropenia in the rat: a model for evaluating efficacy and bioavailability of LTB4 receptor antagonists.

Pellas TC, Colombo C, Fryer LR, Pastor G, Haston W, Raychaudhuri A, Kotyuk B, Greenspan PD, Healy C, DiPasquale G. Pellas TC, et al. Among authors: haston w. J Pharmacol Toxicol Methods. 1993 Nov;30(3):137-42. doi: 10.1016/1056-8719(93)90036-e. J Pharmacol Toxicol Methods. 1993. PMID: 8305713

5

Exposure of human vascular smooth muscle cells to Raf-1 antisense oligodeoxynucleotides: cellular responses and pharmacodynamic implications.

Schumacher C, Cioffi CL, Sharif H, Haston W, Monia BP, Wennogle L. Schumacher C, et al. Among authors: haston w. Mol Pharmacol. 1998 Jan;53(1):97-104. doi: 10.1124/mol.53.1.97. Mol Pharmacol. 1998. PMID: 9443936

6

Measurement of membrane potential responses elicited from blood cells: effect of the dye/cell ratio and the presence of an intracellular calcium probe.

Seligmann B, Haston WO, Wasvary JS, Rediske JR. Seligmann B, et al. Among authors: haston wo. Soc Gen Physiol Ser. 1988;43:233-40. Soc Gen Physiol Ser. 1988. PMID: 3269024 No abstract available.

7

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.

Esser R, Berry C, Du Z, Dawson J, Fox A, Fujimoto RA, Haston W, Kimble EF, Koehler J, Peppard J, Quadros E, Quintavalla J, Toscano K, Urban L, van Duzer J, Zhang X, Zhou S, Marshall PJ. Esser R, et al. Among authors: haston w. Br J Pharmacol. 2005 Feb;144(4):538-50. doi: 10.1038/sj.bjp.0706078. Br J Pharmacol. 2005. PMID: 15655513 Free PMC article.

8

Platelet activating factor stimulates intracellular calcium transients in human neutrophils: involvement of endogenous 5-lipoxygenase products.

Rediske JJ, Quintavalla JC, Haston WO, Morrissey MM, Seligman B. Rediske JJ, et al. Among authors: haston wo. J Leukoc Biol. 1992 May;51(5):484-9. doi: 10.1002/jlb.51.5.484. J Leukoc Biol. 1992. PMID: 1318349

9

Fluorometer based multi-parameter analysis of phagocytic cell activation.

Seligmann B, Patel K, Haston WO, Rediske JJ. Seligmann B, et al. Among authors: haston wo. Agents Actions. 1987 Aug;21(3-4):375-8. doi: 10.1007/BF01966520. Agents Actions. 1987. PMID: 2825487

10

Relationship of blood markers to disease severity and drug efficacy in rat adjuvant arthritis.

Doughty JR, Goldberg RL, Schenkelaars EJ, Singh HN, Peppard J, Haston W, Blancuzzi VJ, Di Pasquale G. Doughty JR, et al. Among authors: haston w. Agents Actions. 1991 Sep;34(1-2):129-31. doi: 10.1007/BF01993257. Agents Actions. 1991. PMID: 1793016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters